Permitted Uses and Disclosures Under HIPAA: Best Practices and Risk Mitigation

Understanding when you may use or disclose Protected Health Information (PHI) is central to HIPAA compliance. This guide explains permitted uses and disclosures under HIPAA, best practices to operationalize them, and practical risk mitigation steps for covered entities and their business associates.

Permitted Uses for Treatment Payment and Healthcare Operations

HIPAA permits using and disclosing PHI without patient authorization for treatment, payment, and healthcare operations (the core authorization exceptions). These activities enable care delivery, reimbursement, and quality improvement while protecting privacy.

Treatment

• Coordination and management of care among providers, consultations, referrals, and medication management.
• Sharing clinically relevant PHI with other treating providers; the Minimum Necessary Requirement does not apply to treatment, though limiting excess data remains a best practice.

Payment

• Billing, claims management, eligibility and coverage determinations, utilization review, and collections.
• Apply the Minimum Necessary Requirement to disclose only the data needed to substantiate the claim or preauthorization.

Healthcare Operations

• Quality assessment, patient safety activities, accreditation, auditing, training, and population-based improvement.
• Disclose the minimum necessary and document role-based access for workforce members who perform these functions.

Operational Tips

• Execute and maintain Business Associate Agreements before sharing PHI with vendors supporting TPO activities.
• Use standard data elements and templates to avoid over-disclosure; log non-routine disclosures for traceability.

Public Interest and Benefit Activities

HIPAA allows specific disclosures without authorization when they advance public policy—often called National Priority Purposes. Each disclosure must be permitted by the rule, limited to the minimum necessary, and documented when required.

Common Categories

• Required by law (e.g., mandated reporting) and to public health authorities for disease reporting, surveillance, or adverse events.
• Health oversight activities such as audits, investigations, and inspections.
• Judicial and administrative proceedings, and certain law enforcement purposes (e.g., locating a missing person or responding to a court order).
• Disclosures about decedents, organ and tissue donation, and coroners or medical examiners.
• Research with an IRB or Privacy Board waiver, or via a Limited Data Set under a Data Use Agreement.
• To avert a serious threat to health or safety, workers’ compensation programs, and specialized government functions.

Best Practices

• Verify legal authority for each disclosure and retain documentation supporting the public interest exception.
• Default to the least-identifiable data feasible; prefer de-identified or limited data sets when full PHI is unnecessary.

Minimum Necessary Standard

The Minimum Necessary Standard (often called the Minimum Necessary Requirement) requires you to limit uses, disclosures, and requests for PHI to the least amount reasonably needed to accomplish the purpose.

When It Applies

• Payment and healthcare operations disclosures.
• Most public interest disclosures unless a law or court order specifies otherwise.
• Internal workforce access for non-treatment functions based on role-based permissions.

Key Exceptions

• Disclosures to or requests by a provider for treatment.
• Disclosures to the individual, or uses/disclosures pursuant to a valid authorization.
• Disclosures required by law and to HHS for compliance investigations.

How to Operationalize

• Create role-based access matrices and standard protocols for routine disclosures; require approval for non-routine cases.
• Use data segmentation, smart defaults, and templates to automatically exclude extraneous fields.
• Apply “reasonable reliance” when responding to requests from public agencies or oversight bodies acting within their remit.

Incidental Uses and Disclosures

Incidental uses or disclosures are permitted when they occur as a byproduct of an otherwise permitted use and when you have reasonable safeguards and minimum necessary controls in place.

Examples

• Names overheard at a nursing station or a patient’s name called in a waiting room.
• PHI briefly visible on a workstation that is promptly locked when unattended.

Safeguards to Expect

• Privacy screens, workstation timeouts, controlled speaking volume, and signage in semi-public areas.
• Policies that forbid discussing PHI in public spaces and require secure disposal of printed materials.

Incidental disclosures resulting from negligence or inadequate safeguards are not protected by this allowance; address root causes quickly.

Risk Mitigation Techniques

Building layered safeguards reduces the likelihood and impact of privacy incidents while enabling compliant workflows.

Administrative Controls

• Enterprise risk analysis, policies for access, sanctions, and an incident response plan with clear escalation paths.
• Training tailored to roles (front desk, clinicians, revenue cycle) and regular phishing and privacy drills.
• Vendor risk management: due diligence, contract clauses, and monitoring of business associates.

Technical Controls

• Encryption at rest and in transit, multi-factor authentication, and least-privilege role design.
• Audit logs, real-time alerts, and data loss prevention to flag mass exports or unusual lookups.
• Mobile device management, automatic patching, and secure messaging for PHI instead of email where feasible.

Physical Controls

• Badge access, visitor procedures, device locking, and secure printing with release codes.
• Clean-desk expectations and controlled storage for media containing PHI.

Using De-identification

• Prefer de-identification (safe harbor or expert determination) when full PHI is not required.
• When identifiers are still needed, use a Limited Data Set with a Data Use Agreement and strong retention/disposal rules.

Mitigation of Harmful Effects

HIPAA imposes a mitigation obligation: if an unauthorized use or disclosure occurs, you must reduce the harmful effects to the extent practicable and evaluate breach notification duties.

Immediate Actions

• Contain and control: sequester misdirected records, disable access, and request return or destruction of PHI.
• Document facts, preserve logs, and notify privacy/security officers and affected business associates.

Risk Assessment and Notification

• Assess nature and extent of PHI involved, the unauthorized recipient, whether PHI was actually viewed/acquired, and mitigation performed.
• If a breach is likely, notify affected individuals without unreasonable delay (and within applicable regulatory timeframes), plus HHS and media when required.

Remediation

• Provide support such as credit monitoring when appropriate, retrain staff, apply sanctions, and fix control gaps.
• Update policies, BAAs, and technical rules to prevent recurrence; track closure of corrective actions.

Prohibited Uses and Disclosures

Any use or disclosure not expressly permitted by HIPAA or authorized by the individual is prohibited. Common pitfalls include overbroad sharing, weak verification, and informal channels that bypass safeguards.

• Marketing communications that require authorization (with narrow exceptions such as face-to-face interactions and nominal gifts).
• Sale of PHI without explicit authorization, including exchanges where remuneration is received.
• Using PHI for employment decisions within a covered entity or for underwriting where prohibited (e.g., genetic information in health plans).
• Disclosing psychotherapy notes without specific authorization, except for limited treatment, training, or defense purposes.
• Research disclosures without authorization, IRB/Privacy Board approval, or a compliant Limited Data Set agreement.

In practice, anchor every decision to a clear permission in the rule, apply the minimum necessary, prefer de-identified data, and document your rationale. These habits reduce risk and reinforce a culture of compliance.

FAQs.

What uses and disclosures does HIPAA permit without authorization?

HIPAA permits PHI uses and disclosures for treatment, payment, and healthcare operations; for specific public interest and benefit activities (National Priority Purposes); and as otherwise required by law. These are authorization exceptions, but you must still apply safeguards and, where applicable, the Minimum Necessary Requirement.

How is the minimum necessary standard applied under HIPAA?

You limit PHI to the least amount reasonably needed for the purpose by using role-based access, standard disclosure protocols, and data minimization tools. It does not apply to disclosures for treatment, to the individual, to HHS, those required by law, or those made pursuant to a valid authorization.

What are examples of permitted public interest disclosures?

Examples include reporting to public health authorities, cooperating with health oversight activities, responding to court orders, certain law enforcement requests, disclosures to coroners and medical examiners, organ and tissue donation facilitation, research under an IRB/Privacy Board waiver or Limited Data Set, addressing serious threats, and workers’ compensation programs.

How should covered entities mitigate harmful effects of unauthorized disclosures?

Act immediately to contain the incident, document facts, and assess risk. If a breach is likely, issue required notifications without unreasonable delay, engage affected business associates, and provide support to individuals as appropriate. Remediate root causes through sanctions, retraining, policy updates, and strengthened technical and physical controls to prevent recurrence.